The results of this study suggest that PPARγ ligands may inhibit leukemic cell adhesion to and invasion through the ECM as well as regulate angiogenesis by inhibiting matrix remodeling that favors cancer cell invasion and EC migration [230]. Here, PPARG is linked to cancer.